ReviewPatient preference and adherence2019

Once-Monthly Subcutaneously Administered Risperidone in the Treatment of Schizophrenia: Patient Considerations.

Lesia V Tchobaniouk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.